Le Lézard
Classified in: Health
Subject: ACC

DSM - Repurchase of Shares (10 - 14 June 2019)


HEERLEN, Netherlands, June 18, 2019 /PRNewswire/ --

Royal DSM, a global science-based company in Nutrition, Health and Sustainable Living, has repurchased 147,395 of its own shares in the period from 10 June 2019 up to and including 14 June 2019 at an average price of ?106.02. This is in accordance with the repurchase announced on 14 March 2019, covering the intended reduction of issued capital as well as commitments under share-based compensation plans and for stock dividends. The consideration of this repurchase was ?15.6 million. 

     (Logo: https://mma.prnewswire.com/media/657851/DSM_Logo.jpg )

The total number of shares repurchased under this program to date is 2,353,355 shares for a total consideration of ?238.9 million.

For more detailed information see 'Daily transaction details Share Repurchase Program announced 14 March 2019'.

DSM - Bright Science. Brighter Living.tm 

Royal DSM is a global, purpose-led, science-based company active in Nutrition, Health and Sustainable Living. DSM's purpose is to create brighter lives for all. DSM addresses with its products and solutions some of the world's biggest challenges while simultaneously creating economic, environmental and societal value for all its stakeholders - customers, employees, shareholders, and society at large. DSM delivers innovative solutions for human nutrition, animal nutrition, personal care and aroma, medical devices, green products and applications, and new mobility and connectivity. DSM and its associated companies deliver annual net sales of about ?10 billion with approximately 23,000 employees. The company was founded in 1902 and is listed on Euronext Amsterdam. More information can be found at http://www.dsm.com.

Or find us on:

Facebook

Twitter

LinkedIn

YouTube

 

    PRN NLD


These press releases may also interest you

at 20:00
Pharmascience Inc. is voluntarily, on a precautionary basis, recalling Ranitidine Tablets 75mg, 150mg and 300 mg (all pack sizes and formats) to the retail level (type 1 recall). On September 13, 2019, further to a...

at 20:00
An October 12 article on Today Online reported on new statistics published by the American Society for Dermatologic Surgery (ASDS) regarding the rise of noninvasive body contouring procedures. According to the ASDS, there are more than 10 nonsurgical...

at 19:47
Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB B) ("Genomma Lab" or "the Company"), today announced its results for the second quarter ended June 30, 2019. All figures included herein are stated in nominal Mexican pesos and have been prepared in...

at 19:15
EXMceuticals Inc. (the "Company" or "EXM") announces that it has applied for a voluntary management cease trade order in accordance with National Policy 12-203 due to it not being able to file its annual financial statements and MD&A for the year...

at 19:15
The "Global Biostimulants Market (by Active Ingredients, Application & Crop Type): Insights, Trends and Forecast (2019-2023)" report has been added to ResearchAndMarkets.com's offering. The global biostimulants market is expected to reach US$3.97...

at 19:04
Original Notice Why should you take note The Public Health Agency of Canada (PHAC) is collaborating with provincial public health partners, the Canadian Food Inspection Agency (CFIA) and Health Canada to investigate an outbreak of Salmonella...



News published on 18 june 2019 at 03:00 and distributed by: